Meta Pixel

News and Announcements

Significant Growth Opportunity – Insync Funds Management Shortlisted for Prestigious Industry Award

  • Published March 12, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Insync Funds Management, a fund manager that was recently showcased at the Emergence 2020 Conference, has been shortlisted for the Money Management Fund Manager of the Year – Emerging Manager. The Money Management Fund Manager of the Year Awards has been going for the past 32 years and are the hallmark for excellence in the Funds Management Industry.

The awards bring together the best and most influential voices in the industry to act as a judging panel. The judging methodology for Money Management’s Fund Manager of the Year 2020 combines FE fundinfo’s quantitative fund data with the expertise of recognised research partners, Lonsec, Mercer, SQM Research and IOOF.

Previous winners of the Emerging Manager category include; Antipodes Partners, Montgomery Investment Management and Paradice Investment Management who have all gone on to raise significant funds under management after winning this prestigious award.

For more information on Insync’s investment offering, click here.

Register Interest

About Insync Funds Management Pty Ltd

Insync Funds Management Pty Ltd is a Sydney-based specialist future focused global equity funds management company established in 2009 that invests in a concentrated portfolio of highly profitable global stocks that have delivered superior returns for our fund investors over a sustained period of 10 years.

Register Interest

 

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now